|
Volumn 107, Issue 8-9, 2014, Pages 476-478
|
Conversion of Brugada type i to type III and successful control of recurrent ventricular arrhythmia with cilostazol
|
Author keywords
Arrhythmia suppression; Brugada syndrome; Cilostazole; Implantable cardioverter defibrillator; Ventricular tachycardia
|
Indexed keywords
CILOSTAZOL;
ANTIARRHYTHMIC AGENT;
PHOSPHODIESTERASE III INHIBITOR;
TETRAZOLE DERIVATIVE;
ADULT;
BREATHING DISORDER;
BRUGADA SYNDROME;
CARDIOVASCULAR MAGNETIC RESONANCE;
CASE REPORT;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAM;
FAINTNESS;
FOLLOW UP;
HEART LEFT VENTRICLE FUNCTION;
HEART VENTRICLE ARRHYTHMIA;
HEART VENTRICLE EXTRASYSTOLE;
HOSPITAL READMISSION;
HUMAN;
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR;
MALE;
NOTE;
POLYMORPHIC VENTRICULAR TACHYCARDIA;
RECURRENT DISEASE;
RESTING HEART RATE;
SINUS RHYTHM;
CARDIOVERSION;
DEVICES;
DRUG EFFECTS;
ELECTROCARDIOGRAPHY;
HEART MUSCLE CONDUCTION SYSTEM;
HEART RATE;
PATHOPHYSIOLOGY;
TACHYCARDIA, VENTRICULAR;
TREATMENT OUTCOME;
ADULT;
ANTI-ARRHYTHMIA AGENTS;
BRUGADA SYNDROME;
DEFIBRILLATORS, IMPLANTABLE;
ELECTRIC COUNTERSHOCK;
ELECTROCARDIOGRAPHY;
HEART CONDUCTION SYSTEM;
HEART RATE;
HUMANS;
MALE;
PHOSPHODIESTERASE 3 INHIBITORS;
RECURRENCE;
TACHYCARDIA, VENTRICULAR;
TETRAZOLES;
TREATMENT OUTCOME;
|
EID: 84906938206
PISSN: 18752136
EISSN: 18752128
Source Type: Journal
DOI: 10.1016/j.acvd.2012.06.008 Document Type: Article |
Times cited : (21)
|
References (0)
|